IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 214 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,093,939 | -88.7% | 113,597 | -87.5% | 0.01% | -89.1% |
| Q2 2023 | $9,649,682 | +162.2% | 906,925 | +159.2% | 0.05% | +155.6% |
| Q1 2023 | $3,680,285 | +132.9% | 349,837 | +174.3% | 0.02% | +100.0% |
| Q4 2022 | $1,580,295 | -43.0% | 127,546 | -47.0% | 0.01% | -35.7% |
| Q2 2022 | $2,772,000 | +794.2% | 240,431 | +876.0% | 0.01% | +600.0% |
| Q1 2022 | $310,000 | -78.2% | 24,634 | -80.7% | 0.00% | -80.0% |
| Q1 2021 | $1,425,000 | +285.1% | 127,473 | +292.0% | 0.01% | +233.3% |
| Q4 2020 | $370,000 | +191.3% | 32,516 | +159.2% | 0.00% | -25.0% |
| Q1 2020 | $127,000 | -74.3% | 12,546 | -66.3% | 0.00% | -60.0% |
| Q4 2019 | $495,000 | – | 37,225 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |